# Volume-controlled inverse ratio ventilation improves safe apnea time in obese patients during the induction of general anesthesia: a randomized controlled trial

**Authors:** Yonghai Zhang, Bin Li, Chang Xu, Yan Wu, Ling Ma, Fan Yang, Hanxiang Ma, Xinli Ni

PMC · DOI: 10.3389/fmed.2025.1574634 · Frontiers in Medicine · 2025-05-01

## TL;DR

Using inverse ratio ventilation in obese patients during anesthesia increases safe apnea time and oxygen levels compared to conventional methods.

## Contribution

This study shows that volume-controlled inverse ratio ventilation improves safe apnea time in obese patients during anesthesia induction.

## Key findings

- Safe apnea time was significantly longer in the inverse ratio ventilation group.
- Expired oxygen fraction was higher in the inverse ratio ventilation group.
- Baseline parameters were comparable between the two groups.

## Abstract

Inverse ratio ventilation theoretically increases oxygenation in obese patients. However, it is unknown whether the use of inverse ratio ventilation prolongs the safe apnea time during the induction of anesthesia. The primary objective of our study was to compare the safe apnea time between obese surgical patients receiving inverse ratio ventilation and conventional ratio ventilation during the induction of anesthesia.

This study is a prospective, randomized controlled trial. Forty obese patients who underwent elective operation under general anesthesia with endotracheal intubation were randomly allocated into the conventional ratio ventilation (CRV) group (n = 20) and inverse ratio ventilation (IRV) group (n = 20). After the patients were preoxygenated through a face mask for 3 min, anesthesia induction was performed. When the patients lost consciousness and spontaneous breathing disappeared, non-invasive positive pressure ventilation was performed for 5 min, and the inspiratory-to-expiratory (I:E) ratio was set as 1:2 in the CRV group and 2:1 in the IRV group. Heart rate, systolic blood pressure, diastolic blood pressure, and pulse oxygen saturation were recorded at four time points: (i) before pre-oxygenation (T0), (ii) pre-oxygenation for 3 min (T1), (iii) non-invasive positive pressure ventilation for 3 min (T2), and (iv) non-invasive positive pressure ventilation for 5 min (T3). Arterial blood was collected at T0, T1, and T3 for arterial blood gas analysis, and arterial oxygen partial pressure and carbon dioxide partial pressure were recorded. The patient’s expiratory oxygen fraction at T1, T2, and T3 were recorded. Peak airway pressure, plateau pressure and mean airway pressure were record at T2 and T3. The safe apnea time was recorded in both groups.

Forty patients completed the study. Baseline parameters were comparable between the two groups. Safe apnea time was significantly longer (210.40 ± 47.47 vs. 153.80 ± 41.54 s, mean difference [95% CI], 56.55 [28.00–85.10], p = 0.0003) and the expired O2 fraction was higher (87.60 ± 2.39 vs. 91.60 ± 1.79, mean difference [95% CI], 4.00 [2.65–5.35], p < 0.0001) at T3 in the IRV group compared to the CRV group.

Volume-controlled inverse ratio ventilation at an I:E ratio of 2:1, compared to conventional ratio ventilation, provided a longer safe apnea time and higher expired O2 fraction in obese patients during the induction of anesthesia.

## Full-text entities

- **Diseases:** respiratory or renal disease (MESH:D012140), obesity hypoventilation (MESH:D010845), Obese (MESH:D009765), obstructive sleep apnea (MESH:D020181), alveolar collapse (MESH:D001261), hypoxemia (MESH:D000860), cerebrovascular disease (MESH:D002561), pulmonary hypertension disease (MESH:D006976), apnea (MESH:D001049), lung injury (MESH:D055370), gastric reflux disease (MESH:D005764), gastric distension (MESH:D013272), restrictive ventilatory disorder (MESH:D012131), ARDS (MESH:D012128), ischemic heart or uncontrolled hypertension (MESH:D017202)
- **Chemicals:** N2 (MESH:D009584), CO2 (MESH:D002245), CRV (-), midazolam (MESH:D008874), O2 (MESH:D010100), sufentanil (MESH:D017409), rocuronium (MESH:D000077123), propofol (MESH:D015742)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12078310/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12078310/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12078310/full.md

---
Source: https://tomesphere.com/paper/PMC12078310